Zosano Pharma Profit Margin

The latest profit margin for ZSAN is -8394.23% as of March 2022. That compares with -6809.54% in the prior-year period — down 23.3% year over year. That is below the Healthcare sector average of 15.58%. Investors often review this figure alongside Zosano Pharma's historical trend and sector peers before judging valuation or financial health.

Over the past year, ZSAN's profit margin moved from -6809.54% to -8394.23% — a 23.3% year-over-year decrease. If the trend continues in the same direction for several quarters, it can signal a meaningful shift in Zosano Pharma's valuation or profitability profile.

Against Healthcare companies, ZSAN currently prints -8394.23% for profit margin, while the sector average sits near 15.58%. That is roughly 53964.3% below the sector mean. Large gaps often invite a closer look at Zosano Pharma's growth, margins, and balance sheet.

Profit Margin shows how effectively Zosano Pharma converts resources into returns. At -8394.23%, ZSAN may look efficient or underperforming depending on peer benchmarks and trend direction. That compares with -6809.54% in the prior-year period — down 23.3% year over year. Pair the percentage with revenue growth and leverage for a fuller health check.

After noting ZSAN's profit margin (-8394.23%), review year-over-year change from -6809.54%, peer averages, and a few neighboring metrics such as revenue, margins, or valuation multiples. That combination usually beats staring at a single figure. The navigation links on this page jump you to those related views.